Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	17.33B
Revenue (ttm)	4.23B
Net Income (ttm)	1.06B
Shares Out	84.72M
EPS (ttm)	12.53
PE Ratio	16.32
Forward PE	14.60
Dividend	7.50 (3.69%)
Ex-Dividend Date	Mar 26, 2025

Volume	96,739
Average Volume	181,709
Open	203.00
Previous Close	203.00
Day's Range	199.50 - 205.50
52-Week Range	193.50 - 275.50
Beta	0.85
RSI	33.40
Earnings Date	Mar 6, 2025

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2024, TPEX:3218's revenue was 4.23 billion, an increase of 3.58% compared to the previous year's 4.08 billion. Earnings were 1.06 billion, an increase of 1.88%.